Laboratory

Highlight on the DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay

Clinical

Discovers our solutions

Advanced Biological Laboratories Signs Non-Binding LOI for Proposed Reverse Merger with ProPhase Labs

Dec 19, 2025

LUXEMBOURG VILLE, LUXEMBOURG, December 19, 2025 /EINPresswire.com/ — Advanced Biological Laboratories S.A. (“ABL”), a European biotechnology and MedTech group, and ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”) today announced that they have entered into a non-binding…
Read more
ABL Luxembourg Announces Second Strategic Agreement with Alumni Capital to Support ABL Diagnostics’ Growth

Oct 23, 2025

ABL Luxembourg Announces Second Strategic Agreement with Alumni Capital to Support ABL Diagnostics’ Growth Luxembourg, October 22, 2025, 6:00 PM CET – Advanced Biological Laboratories S.A. (“ABL Luxembourg”) is pleased to announce the signing of a new share purchase agreement with Alumni Capital, a…
Read more
Advanced Biological Laboratories (ABL) S.A Inks Licensing Agreement with the Institut Pasteur for HPV RNA-Seq Technology

Apr 22, 2025

HPV Transcriptome as a Game-Changing Biomarker for Detection, Genotyping, and Monitoring of HPV-Associated Cervical High-Grade Cytology LUXEMBOURG, LUXEMBOURG, April 22, 2025 /EINPresswire.com/ — Advanced Biological Laboratories (ABL), a diagnostics company, headquartered in Luxembourg, is ple…
Read more

ABL Inks Know-How License and Transfer Agreement for the Fast Track Diagnostics PCR Portfolio from Siemens Healthineers

Feb 06, 2025

ABL and affiliates plan to start the production and commercialization of new UltraGene products based on PCR tests previously supplied by Fast Track Diagnostics ABL Diagnostics SA (EPA:ABLD) LUXEMBOURG VILLE, LUXEMBOURG, February 3, 2025 /EINPresswire.com/ — Advanced Biological Laboratories (A…
Read more
Webinar: E-AHPBA–ESSO–ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy

Nov 14, 2023

22.11.2023 at 4:30 to 6:00 p.m. (CET) These European guidelines for the preoperative measurement of liver function were published in June of this year. This represents an important milestone for the use of the LiMAx test and underlines its importance for the safety of patients and surgeons. In our w…
Read more
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease

Jul 11, 2023

PRINCETON, N.J., July 11, 2023 (GLOBE NEWSWIRE) — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, and Humedics GmbH, a le…
Read more

ABL SA group acquires Berlin based Medtech company Humedics

Dec 15, 2022

ABL SA acquires the company Humedics Gmbh to extend the use of a robust, well-known, and CE-marked technology intended to be used for liver function measurement. Financial terms are not disclosed. Doctor Chalom Sayada, founder of the ABL SA and managing director of the Humedics declared: “We are pr…
Read more
Advanced Biological Laboratories Fedialis SAS (formerly ABL France SAS) is now ABL Diagnostics SA

Sep 02, 2022

On September 1st 2022, Advanced Biological Laboratories Fedialis SAS (formerly ABL France SAS) merged into ABL Diagnostics SA (ABLD), a worldwide leading international company, listed on Euronext Paris compartment C (ISIN FR001400AHX6), offering innovative and proprietary molecular biology assays an…
Read more
REALISATION DE LA FUSION

Aug 31, 2022

Paris, le 31 août 2022, Lors de la réunion du 3 août 2022 et dans le prolongement des communications effectuées à ce sujet, l’assemblée générale des actionnaires de la société ABL Diagnostics (la « Société ») a approuvé le projet de fusion-absorption de la société Advanced Biological Laboratories Fe…
Read more